Interventional rad research program taps Siemens for adv viz

The National Center for Image-Guided Therapy (NCIGT) at Brigham and Women’s Hospital in Boston plans to leverage Siemens Healthcare syngo.via for multimodality visualization.

Supported by the National Institutes of Health, NCIGT is a research group dedicated to advancing image-guided interventional techniques with diagnostic imaging tools coupled with interventional surgical systems.

Co-directed by two radiologists, Ferenc A. Jolesz, MD, and Clare M. Tempany, MD, the NCIGT’s physicians and researchers are committed to less invasive, more patient-centric procedural medicine. They plan to install Siemens syngo.via across Brigham's radiology workstations to provide advanced visualization functionality.

Physicians at the center plan to develop new image-guided therapeutic approaches and to improve a number of validated interventional procedures, including image-guided therapy in open brain surgery, radiation treatment of prostate cancer and gynecological tumors, breast conserving therapy, MRI-guided cryoablation, treatment of atrial and ventricular fibrillation and brain tumor laser ablation.

As they refine their techniques in clinical suites that provide access to integrated advanced imaging modalities, radiologists with the NCIGT are turning to syngo.via to prepare images, enable navigation through cases in line with disease-specific requirements and share it with colleagues and clinical partners.

Around the web

To fully leverage today's radiology IT systems, standardization is a necessity. Steve Rankin, chief strategy officer for Enlitic, explains how artificial intelligence can help.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.